alexa Glycemic Control With Intensive Insulin Treatment Fundamental To Renal Preservation In Diabetes | 14312
ISSN: 2327-5162

Alternative & Integrative Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Conference and Exhibition on Traditional & Alternative Medicine

Anil K. Mandal, Linda M. Hiebert and Harry Khamis
ScientificTracks Abstracts: Altern Integ Med
DOI: 10.4172/2327-5162.S1.002
Abstract
Diabetes is the most common cause of end stage renal disease (ESRD).Previous studies imply angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocking (ARB) drugs contribute to prevalence of ESRD in diabetes. This study investigates renal preservation in diabetes by intensive insulin therapy. Methodology: 46 adult diabetes patients, 28 female, 18 male, were studied for mean 14.2 months (1.5-115 months). Diabetes was diagnosed by 2-h postprandial glucose of ≥ 200mg/dL (11.1 mmol/L) and treated by Glargine or detemir insulin after breakfast and dinner, with regular insulin by finger-stick glucose 2-h post-meal and bedtime. Blood pressure (BP) was controlled with anti- hypertensive therapy excluding ACEI/ARB drugs. Glucose, serum creatinine (Scr), estimated glomerular filtration rate (eGFR), and glycosylated hemoglobin at first and last visits were obtained. BP was recorded in both visits. Results were compared between first and last visits. A paired two-tailed test P <0.05 was significant. Patients were divided by 2hPP glucose of < or > 11.1 mmol/L. Results: Glucose at last visit was significantly lower (8.4?0.6 mmol/L) than first visit (10.3?0.7 mmol/L) in all patients group associated with significantly reduced Scr in last visit (100.3?5.2 μm0l/L) compared to first visit (110.9+7.8 μmol/L). No change in eGFR was noted between first and last visits. Significant reduction of HbA1c (9.14?0.52 v. 7.60?0.45 p < 0.0148) was found in less than 11.1 mmol/L group. BP?s were normal (<140/80mmHg) in both visits in all groups. Conclusion: The paradigm of therapy presented in this study is proven effective in renal preservation in diabetes.
Biography
Anil K. Mandal completed his MBBS (equivalent to M.D.) at the age of 24 from Calcutta University in India. He received his nephrology training at the University of Illinois, Chicago and has done extensive research on hypertension, diabetes, and kidney disease. He has published more than 200 papers and abstracts as well as 12 books. He has been a Visiting Professor in 24 countries including numerous times in India, and is a courtesy clinical Professor of the University of Florida, Gainesville. He is dedicated to changing the direction of diabetes care in order to help diabetics live a complication-free life.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version